This most up-to-date twist from the Lykos Therapeutics saga threatens a major overhaul of the corporate’s strategy and direction, with Musk ally and billionaire Trader Antonio Gracias appearing to choose to acquire the company back again toward its nonprofit drug progress roots and a far more Doblinite philosophy.“invention” of a copyright Va